Historical medicines Historical regulatory record Hormone research
Also discussed as: Geref, sermorelin acetate
What it is and how it works
Sermorelin is a growth hormone-releasing hormone analogue with a historical role in growth-hormone testing and treatment. Historical product use provides context, but it does not establish a contemporary compounded product’s identity, quality, or effectiveness for another purpose.
Source for the mechanism context →A closer look at the cited evidence
Historical regulatory record
This label describes the selected source below. It is not a complete ranking of the literature, a safety score, or an approval status.
- Study or assessment
- FDA — 2013 Geref withdrawal determination
- Design
- Regulatory notice concerning discontinued Geref products; not a new clinical trial.
- Who or what was studied
- Historical diagnostic and pediatric treatment indications described in the notice.
- What was observed
- FDA determined the products were not withdrawn from sale for safety or effectiveness reasons.
- Limits of interpretation
- That determination is not approval of anti-aging use, a combination protocol, or any present-day compounded preparation.
What the evidence means
Historical approval for a defined use does not validate contemporary anti-aging claims or compounded formulations.
Approval and regulatory context
Geref products were discontinued and their approvals withdrawn. FDA later determined they were not withdrawn for safety or effectiveness reasons. This history does not confer approval on a compounded product.
Safety and uncertainty
Historical regulatory findings should not be interpreted as a complete safety assessment for a different formulation or use.
What remains uncertain
The unanswered question in wellness marketing is whether a specific contemporary product improves a meaningful health outcome in the population being targeted. A historical approval story cannot answer that question.
These summaries are introductory and are not a complete account of the literature, adverse effects, contraindications, or interactions. Absence of a listed risk does not mean absence of risk. Different compounds, formulations, and routes cannot be treated as interchangeable.
Sources behind this overview
Read the source in its full context. Source links support the overview; they do not imply endorsement of this library by the source organization.